Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Choosing between equal and cap weight depends on goals and risk tolerance. This quick guide compares the two for retirement suitability.
24,468 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
A landmark innovator, Ted Turner reshaped TV by launching CNN, expanding cable, and preserving Hollywood classics. Th...
Bitcoin rebounds into the $70k-$80k zone, but pandemic-style health headlines loom over the market. Traders weigh whe...
Physical gold and silver flows to vaults and banks are accelerating in 2026, signaling potential strains on fiat curr...
Seven months into fiscal 2026, the deficit surged to $955 billion, intensifying pressure on policymakers to restrain ...
A billionaire investor backed D-Wave Quantum in late 2024, and the stock has surged and slumped in a choppy 2026 trad...
A prominent investment advisor just made a sizable play in a well-known theme park company. This article dives into t...
Ethereum faces renewed selling pressure as ether trader sentiment falls to its lowest level in three years. The signa...
Ethereum is sliding again as on-chain data show a widening gap between futures bets and spot demand, with dip buyers ...
As SpaceX moves toward a historic public listing, Antonio Gracias could see his private stake surge into the tens of ...
In a high-rate environment, Verizon’s steady cash flow and dividend attract institutional buyers. Here’s why it’s gai...
A teen who left school to work on his dad’s site rose to a six-figure construction business by 22. The story mirrors ...